CB ESPRi
VC Fund
Bratislava, Slovakia (Slovak Republic)
CB ESPRi is a VC fund in Bratislava focused on Big Data and Health Diagnostics. Impact Investing Fund
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries CB ESPRi invests in
Stages CB ESPRi invests in
Countries CB ESPRi invests in
Investment Focus
Industry
- Big Data 2 (67%)
- Health Diagnostics 2 (67%)
- Information Technology 2 (67%)
- Artificial Intelligence 2 (67%)
- Internet 1 (33%)
Country
- Slovakia (Slovak Republic) 2 (67%)
- The Netherlands 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Organizations work with us in two ways. We help you connect to providers of 1) health data or 2) AI services to improve your products in Digital Health, MedTech, BioTech. You don't need to spend 18 months contacting hospitals and research centers with your data request. Talk to us and we will get you connected to health data. We do thingsdifferently than other online marketplaces. You will find confidential workflows and features explicitly adopted to our niche. Our expertise in the life science sector gives our clients a safe space to express their needs for data or any other product-related Solutions. Suppose your Challenge requires a sequence of Solutions. We take care of that as well. | $938.5K / Seed / Aug 27, 2024 | |
|
|
elv.ai operates as an internet safety start-up. | $547.2K / Seed / Jan 15, 2024 | |
|
|
Powerful Medical's PMcardio® is an AI-powered cardiovascular diagnostics and care coordination platform that transforms any 12-lead ECG—paper, scan, image, or digital—into an instant, expert-level diagnostic tool on any smartphone or computer. Powered by Queen of Hearts™, our FDA breakthrough-designated STEMI detection model, PMcardioidentifies true STEMI and STEMI-equivalent patterns with far greater accuracy than traditional criteria. Already used by 100,000 clinicians and detecting 36,000 heart attacks in H1/25 alone, PMcardio has been recognized as a strategic EU priority with a $46M non-dilutive R&D grant, and we are now seeking a $25M partner to commercialize in the U.S.Trained on 2.5 million clinically validated ECGs and proven in 15+ clinical studies, Queen of Hearts™ delivers twice the sensitivity for early STEMI detection and reduces false positives by 90%, cutting door-to-balloon times by an average of 48 minutes. PMcardio closes critical diagnostic gaps—especially in non-PCI and rural settings—ensuring faster, more accurate triage and timely access to life-saving PCI therapy.Powerful Medical has been recognized by the AHA, Google for Startups, and has won the 2025 MedTech Innovator Program! | $9.5M / Seed / Sep 28, 2022 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does CB ESPRi invest in?
CB ESPRi invests primarily in Big Data, Health Diagnostics and Information Technology startups, most often at Seed stage. Most of the 3 investments tracked by Shizune back companies in Slovakia (Slovak Republic). The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did CB ESPRi last invest?
The most recent investment recorded for CB ESPRi closed in Aug 2024. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!